F

Forge Nano

Develops nanocoatings to enhance manufacturing performance

Technical Semiconductor Engineer

Full-TimeUpdated on 10/23/2026
NT$2.8M - NT$3.3M/yr+ 20%–35% target annual incentive + Company-paid business travel
Senior
Master's
Hsinchu, Hsinchu City, Taiwan
In PersonPrimarily based in the Hsinchu office; requires 30%–50% travel throughout APAC excluding China.
Solution EngineeringPre-Sales Solution Engineering, Implementation & Technical Account Management

About the job

Requirements
  • A master's degree in Engineering, Materials Science, Physics, Chemistry, Semiconductor Technology, or another related STEM discipline is required; equivalent technical qualifications combined with relevant commercial experience may be considered.
  • At least 7 years of successful experience in technical sales, applications engineering, business development, field engineering, or other customer-facing semiconductor roles.
  • Experience supporting semiconductor equipment, vacuum systems, thin films, atomic layer deposition, chemical vapor deposition, physical vapor deposition, advanced materials, or related capital equipment markets.
  • Working knowledge of atomic layer deposition and thin-film deposition technologies and their applications in semiconductor manufacturing, electronics, energy storage, or advanced materials processing.
  • Technical aptitude to understand complex manufacturing processes and communicate value-based solutions effectively.
  • Written, verbal, presentation, and customer engagement skills.
  • Problem-solving abilities and strategic thinking skills.
  • Hands-on experience using customer relationship management platforms.
  • Fluency in Mandarin Chinese and professional-level English.
  • Legal authorization to work in Taiwan and ability to travel extensively throughout APAC excluding China.
  • Ability to wear required personal protective equipment in production, fabrication, laboratory, or manufacturing environments and adhere to company safety policies, facility procedures, and applicable health protocols.
  • Ability to routinely communicate with customers and colleagues through presentations, meetings, and discussions; frequently use computers and communication devices; and stand, walk, reach, and handle equipment or demonstration materials.
  • Ability to occasionally work near operating equipment and manufacturing systems.
Responsibilities
  • Develop a deep understanding of Forge Nano's atomic layer deposition equipment, customer applications, and value proposition for semiconductor manufacturers and advanced technology companies.
  • Identify, qualify, and advance new business opportunities across APAC excluding China, with primary emphasis on Taiwan, Japan, Korea, Singapore, and Southeast Asia.
  • Build and maintain an opportunity pipeline while supporting regional sales growth objectives.
  • Monitor semiconductor industry trends, customer technology roadmaps, emerging applications, and competitive developments.
  • Support strategic account development initiatives focused on long-term revenue growth and customer retention.
  • Represent Forge Nano at trade shows, technical conferences, customer visits, industry forums, and partner meetings throughout the region.
  • Lead technical discovery discussions to understand customer process requirements, manufacturing challenges, and commercial objectives.
  • Translate customer needs into Forge Nano solution opportunities and collaborate with Applications, Engineering, Sales, and Service teams to develop proposals.
  • Provide technical guidance through pre-sales evaluations, feasibility studies, demonstrations, acceptance testing, troubleshooting, and post-sale support.
  • Support customer qualification efforts involving atomic layer deposition, thin-film deposition, advanced materials, and semiconductor manufacturing processes.
  • Develop technical proposals, quotations, commercial presentations, and customer documentation.
  • Communicate complex technical concepts to engineering and executive audiences.
  • Develop and maintain relationships with existing customers, strategic accounts, channel partners, and semiconductor ecosystem stakeholders.
  • Support customer satisfaction, repeat business opportunities, installed-base growth, and long-term account development.
  • Coordinate customer communications and project activities across internal functions.
  • Provide ongoing technical and commercial support throughout the customer lifecycle.
  • Help customers evaluate process improvements, production objectives, and technology adoption strategies.
  • Provide technical input for product positioning, messaging, marketing collateral, presentations, webinars, and customer-facing content.
  • Support development of regional marketing strategies and market awareness initiatives.
  • Maintain accurate records of customer interactions, opportunities, forecasts, and sales activities in customer relationship management systems.
  • Support commercial planning, pipeline reviews, forecasting activities, and business reporting.
  • Collaborate with global teams to support strategic initiatives and business growth objectives.
  • Work primarily from the Hsinchu, Taiwan office and interact regularly with semiconductor manufacturers, research organizations, channel partners, and technology stakeholders throughout APAC excluding China.
  • Travel approximately 30%–50% throughout APAC excluding China for customer facilities, industry conferences, trade shows, partner organizations, and strategic account meetings.
Desired Qualifications
  • HubSpot experience.
  • Additional Japanese or Korean language capability.
  • Experience supporting semiconductor fabs, foundries, integrated device manufacturers, outsourced semiconductor assembly and test providers, original equipment manufacturers, or advanced manufacturing companies.
  • Direct experience with semiconductor process development, equipment qualification, or thin-film applications.
  • Established relationships within APAC semiconductor markets outside mainland China.
  • Experience working in fast-paced, high-growth technology organizations.

About the company

Forge Nano develops and deploys Atomic Armor, a nanocoating that enhances manufactured products, especially in semiconductors and powders. Atomic Armor is deposited at the nanoscale onto surfaces or powders, improving battery life, fuel stability, medicine shelf life, and wafer durability. The company differentiates itself with a scalable, industry-grade coating platform proven across diverse materials, building on its lab-to-commercial scaling heritage from the University of Colorado ALD group. Its goal is to help manufacturers boost performance and sustainability by applying durable nanoscale coatings at scale.

Company Size

51-200

Company Stage

IPO

Headquarters

Thornton, Colorado

Founded

2011

Get referred to Forge Nano

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • September 22, 2026 registration became effective, clearing a major hurdle for the NASDAQ listing.
  • Samsung SDI invested $20 million and committed conditional cell purchases starting in 2028.
  • DOE-backed Morrisville expansion targets 3 GWh annually and more than 250 North Carolina jobs.

What critics are saying

  • ATII merger still needs October 16, 2026 shareholder approval; failure blocks public listing.
  • Morrisville gigafactory starts in 2028, leaving execution risk before any scaled battery revenue.
  • Forge Nano’s $40 million 2026 revenue target is small against a $300 million buildout.

What makes Forge Nano unique

  • Atomic Armor spans semiconductors, batteries, and pharma, extending Forge Nano beyond one market.
  • Samsung SDI partnership gives Forge Nano manufacturing know-how and a 2028 procurement path.
  • Nanexa JDA on September 22, 2026 validates ALD coatings in GMP pharmaceutical equipment.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Disability Insurance
  • Life Insurance
  • Paid Holidays
  • Paid Vacation
  • Health Savings Account/Flexible Spending Account
  • 401(k) Retirement Plan
  • 401(k) Company Match

Growth & Insights and Company News

6 month growth

0%

1 year growth

-1%

2 year growth

-3%
Yahoo Finance
Oct 16th, 2026
Archimedes Tech SPAC II shareholders approve Forge Nano merger, Nasdaq debut as "NANO" imminent

Shareholders of Archimedes Tech SPAC Partners II Co. (ATII), a Nasdaq-listed special purpose acquisition company, approved its business combination with Forge Nano, Inc. at an Extraordinary General Meeting on October 16, 2026. The deal is expected to close in the coming days, subject to remaining closing conditions. The combined company will operate as Forge Nano Holdings, Inc. and plans to trade on Nasdaq under the ticker symbols "NANO" for shares and "NANOW" for warrants. Forge Nano is a US semiconductor equipment and advanced materials company. It uses Atomic Layer Deposition technology for AI-era chip manufacturing and defence battery applications. ATII raised $230 million in its February 2025 IPO. Its earlier SPAC merged with SoundHound AI, Inc. in April 2022.

PCI Magazine
Oct 13th, 2026
Forge Nano Raises $20 million in Series A Funding

Forge Nano, formerly PneumatiCoat Technologies, a Colorado-based startup that has innovated a breakthrough technology to enable precision nano-coatings at scale for manufacturing, has closed a Series A investment of $20 million to expand its manufacturing capacity.

Ohsem.me
Sep 22nd, 2026
Forge Nano and Nanexa enter Joint Development Agreement to advance manufacturing for ald-coated PharmaShell(R) long-acting injectable medicines.

Forge Nano and Nanexa enter Joint Development Agreement to advance manufacturing for ald-coated PharmaShell(R) long-acting injectable medicines. 22/09/2026 * Collaboration intended to develop large-scale, GMP-compliant ALD manufacturing equipment supporting Nanexa's broad portfolio of proprietary and partnered PharmaShell(R) programs. DENVER and UPPSALA, Sweden, Sept. 22, 2026 (GLOBE NEWSWIRE) - Forge Nano, Inc., a leading U.S.-based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for artificial intelligence ("AI")-era chip manufacturing and defense battery applications, which has signed an agreement to merge with Archimedes Tech SPAC Partners II Co. ("Archimedes II") (NASDAQ: ATII), today announced a Joint Development Agreement ("JDA") with Nanexa AB to develop scalable pharmaceutical manufacturing capabilities for Nanexa's PharmaShell(R) drug delivery platform and its portfolio of proprietary and partnered programs. Under the agreement, Forge Nano and Nanexa will collaborate on the development of a large scale GMP-compliant ALD manufacturing equipment intended to support clinical development and potential future commercial-scale production across the Nanexa's PharmaShell(R) portfolio. The infrastructure and process know-how potentially gained through the collaboration will find its use in multiple PharmaShell(R)-enabled therapeutic programs. Nanexa's PharmaShell(R) technology is designed to enable long-acting formulations through precisely engineered nanoscale coatings using the ALD technology. The platform can be applied to a broad range of active pharmaceutical ingredients, including small molecules and biologics, across multiple therapeutic areas. The collaboration combines Nanexa's expertise in drug delivery and pharmaceutical development with Forge Nano's capabilities in industrial ALD process development and equipment engineering. The broad potential of the platform is further illustrated by NEX-22, Nanexa's proprietary GLP-1 programme, where preclinical and clinical proof of concept have demonstrated the feasibility of achieving a once-monthly depot formulation. "This agreement demonstrates the potential to apply Forge Nano's ALD expertise to pharmaceutical manufacturing, where process control, repeatability, and scalability are critical," said Paul Lichty, Chief Executive Officer of Forge Nano. "Through this collaboration, we intend to establish flexible manufacturing capabilities that can support a wide range of PharmaShell(R)-enabled products as they progress towards clinical and commercial scale." The agreement builds on the companies' existing relationship and is intended to create a pathway towards increased manufacturing capacity as Nanexa's proprietary and partnered PharmaShell(R) programs progress through development. These include Nanexa's internal product portfolio, its license agreement with Moderna and other undisclosed collaborations with pharmaceutical companies. Any future commercialization of PharmaShell(R)-enabled products remain subject to successful development, regulatory approvals and other factors. "This collaboration is an important milestone, and the timing of the partnership is well aligned with our project portfolio and provides a clear path towards increased manufacturing capacity as our projects advance" said David Westberg, CEO of Nanexa. "As our programs progress and interest from pharmaceutical partners continues to increase, access to scalable manufacturing solutions becomes increasingly important. Forge Nano brings substantial expertise in industrial ALD technology and will help position Nanexa for future commercial manufacturing needs," said Mårten Rooth, CTO of Nanexa. ABOUT FORGE NANO Forge Nano is a leading U.S. based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for AI-era chip manufacturing and defense battery applications via its platform technology, Atomic Armor. Atomic Armor is a scalable, adaptable nano-scale coating system that strengthens America's most critical systems - at the atomic level. The superior surface coatings produced by Forge Nano's Atomic Armor process allow partners to unlock peak performance. Learn more at https://www.forgenano.com. ABOUT NANEXA Nanexa is bringing the control, precision and versatility of Atomic Layer Deposition (ALD) technology to drug formulation. The company's proprietary PharmaShell(R) platform is a unique drug delivery system that enables a high drug load, thus low injection volume, creating a new generation of 'super generic' formulations that will provide greater convenience and reduce costs in the treatment of conditions such as metabolic diseases like type 2 diabetes and obesity, hematology/oncology, cardiovascular disorders, psychiatry, and many others. Nanexa develops its own products and also has collaboration agreements with several pharma companies, including the latest license and option agreement with Moderna. Nanexa's share is listed on Nasdaq First North Growth Market in Stockholm (NANEXA). Media Contact Will McKenna Brand Communications Director, Forge Nano [email protected] 02/07/2026 18/08/2014 13/05/2026 27/04/2026 30/04/2026 Discover more Deploy Enterprise Cloud Latest gadgets

GlobeNewswire
Sep 22nd, 2026
Forge Nano and Nanexa enter Joint Development Agreement to advance manufacturing for ald-coated PharmaShell(R) long-acting injectable medicines.

Forge Nano and Nanexa enter Joint Development Agreement to advance manufacturing for ald-coated PharmaShell(R) long-acting injectable medicines. September 22, 2026 08:47 ET | Source: Forge Nano * Collaboration intended to develop large-scale, GMP-compliant ALD manufacturing equipment supporting Nanexa's broad portfolio of proprietary and partnered PharmaShell(R) programs. DENVER and UPPSALA, Sweden, Sept. 22, 2026 (GLOBE NEWSWIRE) - Forge Nano, Inc., a leading U.S.-based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for artificial intelligence ("AI")-era chip manufacturing and defense battery applications, which has signed an agreement to merge with Archimedes Tech SPAC Partners II Co. ("Archimedes II") (NASDAQ: ATII), today announced a Joint Development Agreement ("JDA") with Nanexa AB to develop scalable pharmaceutical manufacturing capabilities for Nanexa's PharmaShell(R) drug delivery platform and its portfolio of proprietary and partnered programs. Under the agreement, Forge Nano and Nanexa will collaborate on the development of a large scale GMP-compliant ALD manufacturing equipment intended to support clinical development and potential future commercial-scale production across the Nanexa's PharmaShell(R) portfolio. The infrastructure and process know-how potentially gained through the collaboration will find its use in multiple PharmaShell(R)-enabled therapeutic programs. Nanexa's PharmaShell(R) technology is designed to enable long-acting formulations through precisely engineered nanoscale coatings using the ALD technology. The platform can be applied to a broad range of active pharmaceutical ingredients, including small molecules and biologics, across multiple therapeutic areas. The collaboration combines Nanexa's expertise in drug delivery and pharmaceutical development with Forge Nano's capabilities in industrial ALD process development and equipment engineering. The broad potential of the platform is further illustrated by NEX-22, Nanexa's proprietary GLP-1 programme, where preclinical and clinical proof of concept have demonstrated the feasibility of achieving a once-monthly depot formulation. "This agreement demonstrates the potential to apply Forge Nano's ALD expertise to pharmaceutical manufacturing, where process control, repeatability, and scalability are critical," said Paul Lichty, Chief Executive Officer of Forge Nano. "Through this collaboration, we intend to establish flexible manufacturing capabilities that can support a wide range of PharmaShell(R)-enabled products as they progress towards clinical and commercial scale." The agreement builds on the companies' existing relationship and is intended to create a pathway towards increased manufacturing capacity as Nanexa's proprietary and partnered PharmaShell(R) programs progress through development. These include Nanexa's internal product portfolio, its license agreement with Moderna and other undisclosed collaborations with pharmaceutical companies. Any future commercialization of PharmaShell(R)-enabled products remain subject to successful development, regulatory approvals and other factors. "This collaboration is an important milestone, and the timing of the partnership is well aligned with our project portfolio and provides a clear path towards increased manufacturing capacity as our projects advance" said David Westberg, CEO of Nanexa. "As our programs progress and interest from pharmaceutical partners continues to increase, access to scalable manufacturing solutions becomes increasingly important. Forge Nano brings substantial expertise in industrial ALD technology and will help position Nanexa for future commercial manufacturing needs," said Mårten Rooth, CTO of Nanexa. ABOUT FORGE NANO Forge Nano is a leading U.S. based semiconductor equipment and advanced materials company pioneering Atomic Layer Deposition ("ALD") technology for AI-era chip manufacturing and defense battery applications via its platform technology, Atomic Armor. Atomic Armor is a scalable, adaptable nano-scale coating system that strengthens America's most critical systems - at the atomic level. The superior surface coatings produced by Forge Nano's Atomic Armor process allow partners to unlock peak performance. Learn more at https://www.forgenano.com. ABOUT NANEXA Nanexa is bringing the control, precision and versatility of Atomic Layer Deposition (ALD) technology to drug formulation. The company's proprietary PharmaShell(R) platform is a unique drug delivery system that enables a high drug load, thus low injection volume, creating a new generation of 'super generic' formulations that will provide greater convenience and reduce costs in the treatment of conditions such as metabolic diseases like type 2 diabetes and obesity, hematology/oncology, cardiovascular disorders, psychiatry, and many others. Nanexa develops its own products and also has collaboration agreements with several pharma companies, including the latest license and option agreement with Moderna. Nanexa's share is listed on Nasdaq First North Growth Market in Stockholm (NANEXA). Media Contact Will McKenna Brand Communications Director, Forge Nano [email protected]

Associated Press
Sep 17th, 2026
Forge Nano expands AI partnership with Voltaiq for battery development at new 3 GWh gigafactory

Forge Nano has expanded its partnership with Voltaiq to integrate artificial intelligence across its battery operations. The collaboration will embed Voltaiq's Battery Intelligence platform throughout Forge Nano's US battery development and production facilities. As Forge Nano scales towards high-volume manufacturing, it will use AI to accelerate development, improve quality and provide faster insights. The company recently broke ground on a 3 GWh/year gigafactory in Morrisville, North Carolina, targeting high-performance defence and aerospace applications. Voltaiq's enterprise software will support the entire product lifecycle, enabling engineers to rapidly identify manufacturing anomalies, quality issues and equipment problems during production. The platform unifies electrochemical, materials and process data, giving engineers visibility into performance differences. Forge Nano is merging with Archimedes Tech SPAC Partners II Co.